Literature DB >> 8335400

Loss of heterozygosity on chromosome 13 and its association with delayed growth of retinoblastoma.

M V Kato1, K Ishizaki, Y Ejima, A Kaneko, H Tanooka, M S Sasaki.   

Abstract

Loss of heterozygosity (LOH) on chromosome 13 and the age of patients at operation were studied in 46 cases of retinoblastoma (RB) tumors, of which 25 were hereditary and 21 were non-hereditary. The frequency of LOH was 70% for all informative tumors, but significantly higher in non-hereditary tumors (90%) than in hereditary ones (52%). Our results suggest that LOH might be involved in the initial somatic events in non-hereditary tumors. Age at operation of patients with hereditary tumors was significantly lower than that of patients with non-hereditary tumors. Even when tumors associated with a family history were omitted from among the hereditary cases, the difference was still significant. In the case of hereditary tumors, age at operation of LOH-negative patients was significantly lower than that of LOH-positive patients. When tumors associated with a family history were omitted, the difference was still significant. The delay in development of LOH-positive tumors suggests that LOH for one chromosome 13 may be disadvantageous with respect to growth of RB tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335400     DOI: 10.1002/ijc.2910540609

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma.

Authors:  D R Lohmann; M Gerick; B Brandt; U Oelschläger; B Lorenz; E Passarge; B Horsthemke
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

2.  Genomic imprinting of the human serotonin-receptor (HTR2) gene involved in development of retinoblastoma.

Authors:  M V Kato; T Shimizu; M Nagayoshi; A Kaneko; M S Sasaki; Y Ikawa
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

3.  Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling.

Authors:  K C Sippel; R E Fraioli; G D Smith; M E Schalkoff; J Sutherland; B L Gallie; T P Dryja
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

4.  Mitotic recombination map of 13cen-13q14 derived from an investigation of loss of heterozygosity in retinoblastomas.

Authors:  S A Hagstrom; T P Dryja
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  Parental origin of germ-line and somatic mutations in the retinoblastoma gene.

Authors:  M V Kato; K Ishizaki; T Shimizu; Y Ejima; H Tanooka; J Takayama; A Kaneko; J Toguchida; M S Sasaki
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

6.  Detection of mutations of the RB1 gene in retinoblastoma patients by using exon-by-exon PCR-SSCP analysis.

Authors:  T Shimizu; J Toguchida; M V Kato; A Kaneko; K Ishizaki; M S Sasaki
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

7.  Retinoblastoma in India : microsatellite analysis and its application in genetic counseling.

Authors:  Vedam L Ramprasad; Jagadeesan Madhavan; Sakthivel Murugan; Jagadeesh Sujatha; Seshadri Suresh; Tarun Sharma; Govindasamy Kumaramanickavel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

8.  Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma.

Authors:  D R Lohmann; B Brandt; W Höpping; E Passarge; B Horsthemke
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

9.  Mutation spectrum of RB1 gene in unilateral retinoblastoma cases from Tunisia and correlations with clinical features.

Authors:  Hajer Ayari-Jeridi; Kimberly Moran; Amel Chebbi; Hédi Bouguila; Imen Abbes; Khaoula Charradi; Amel Benammar-Elgaaïed; Arupa Ganguly
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

10.  Genotyping of Polymorphic Microsatellite Markers Linked to RB1 Locus in Iranian Population.

Authors:  Saman Mohamad Zahery; Kioomars Saliminejad; Hamid Reza Khorram Khorshid; Ali Ahani
Journal:  Avicenna J Med Biotechnol       Date:  2012-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.